The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,168.00
Bid: 12,854.00
Ask: 11,430.00
Change: -78.00 (-0.64%)
Spread: -1,424.00 (-11.078%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks fall as virus cases rise; U.S. dollar edges higher

Mon, 04th Jan 2021 20:27

* U.S. stocks sharply lower in afternoon trading

* Gold prices rally

* U.S. bond prices fall
(Updates with closing oil prices)

By Caroline Valetkevitch

NEW YORK, Jan 4 (Reuters) - U.S. stocks dropped more than 1%
on Monday, the first trading day of the new year, pulling back
after recent gains to record highs, while the U.S. dollar was up
slightly.

Stocks hit record highs early in the session as investors
focused on the rollout of COVID-19 vaccines, but sentiment
quickly turned cautious over the path of the virus, which
continues to spread amid the discovery of a new variant.

The outcome of runoff elections on Tuesday in Georgia for
two U.S. Senate seats added to the nervousness.

"Investors are feeling a bit nervous on the first trading
day of the new year, and I think this is a confluence of
factors," said Lindsey Bell, chief investment strategist at Ally
Invest, in Charlotte, North Carolina.

MSCI's All-Country World Index, which tracks
stocks across 49 countries, was down 0.7% after earlier hitting
a record high.

The Dow Jones Industrial Average fell 492 points, or
1.61%, to 30,114.48, the S&P 500 lost 64.89 points, or
1.73%, to 3,691.18 and the Nasdaq Composite dropped
210.31 points, or 1.63%, to 12,677.98.

The pan-European STOXX 600 index rose 0.67%, while
Britain's FTSE 100 index closed up 1.7% on its first
post-Brexit trading day.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

With the lag between a full vaccine rollout and a global
economic recovery, investors will count on central banks to keep
money cheap.

Minutes of the Federal Reserve's Dec. 15-16 policy meeting
are due on Wednesday and should offer more details on
discussions about making the U.S. central bank's forward policy
guidance more explicit and the chance of a further increase in
asset purchases this year.

Friday brings the U.S. employment report for December.

In currencies, the U.S. dollar recovered after falling to
its lowest level since April 2018.

The dollar index rose 0.169%, with the euro up
0.88% to $1.2244.

The Japanese yen strengthened 0.08% versus the greenback to
103.12 per dollar, while Sterling was last trading at
$1.3556, down 0.84% on the day.

Gold prices were up more than 2%, while U.S. crude
futures fell 1.9% to settle at $47.62 a barrel and Brent
futures dropped 1.4% to $51.09.

U.S. Treasury yields edged higher as traders repositioned at
the start of trading in the new year. Benchmark 10-year Treasury
notes last fell 1/32 in price to yield 0.9148%.

(Additional reporting by Ritvik Carvalho in London and by Medha
Singh and Shivani Kumaresan in Bengaluru; Editing by Toby
Chopra, Dan Grebler and Paul Simao)

More News
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.